November 12, 2018
Takeda Pharmaceutical said on November 12 that it has decided to call an extraordinary shareholders meeting on December 5, which will serve as a de-facto vote on the proposed acquisition of London-listed Shire. The Japanese drug juggernaut will hold the...read more